Research programme: CCR6 pathway modulators - Biokine

Drug Profile

Research programme: CCR6 pathway modulators - Biokine

Alternative Names: BKT150

Latest Information Update: 29 Jan 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Biokine Therapeutics
  • Class
  • Mechanism of Action Chemokine modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Autoimmune disorders; Cancer

Most Recent Events

  • 29 Jan 2016 Discontinued for Autoimmune disorders in Israel (IV)
  • 29 Jan 2016 Discontinued for Cancer in Israel (IV)
  • 07 Jul 2011 Early research in Autoimmune disorders in Israel (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top